We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · July 17, 2021

NSAID Drug Use and COVID-19 Outcomes

The Lancet. Rheumatology


Additional Info

The Lancet. Rheumatology
Non-Steroidal Anti-Inflammatory Drug Use and Outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK Cohort: A Matched, Prospective Cohort Study
Lancet Rheumatol 2021 Jul 01;3(7)e498-e506, TM Drake, CJ Fairfield, R Pius, SR Knight, L Norman, M Girvan, HE Hardwick, AB Docherty, RS Thwaites, PJM Openshaw, JK Baillie, EM Harrison, MG Semple

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading